Skip to main content
VREOF
OTC Life Sciences

Vireo Growth to Acquire Planet 13 in All-Stock Deal, Adding 36 Dispensaries and Expanding Multi-State Cannabis Footprint

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Healthcare
Sentiment info
Positive
Importance info
9
Price
$9.37
Mkt Cap
$433.339M
52W Low
$8.91
52W High
$24
52W Position info
5.2% above low
Off High info
61% below high
Rel. Volume info
1.6× avg
Market data snapshot near publication time

VREOF is trading near its 52-week low of $8.91 (5.2% above the low).

Summary

Vireo Growth Inc. signed a definitive merger agreement to acquire Planet 13 Holdings Inc. in an all-stock deal, issuing approximately 5.6 million shares and adding 36 dispensaries across four states.


Key Events · M&A and Partnerships · VREOF

  • All-Stock Merger Agreement Signed

    Vireo Growth Inc. entered into a definitive agreement to acquire Planet 13 Holdings Inc. Planet 13 shareholders will receive 0.015383618 Vireo subordinate voting shares per Planet 13 share, implying issuance of approximately 5.6 million Vireo shares based on Planet 13's fully diluted share count of ~365.5 million.

  • Expands Retail Footprint by 36 Dispensaries

    The acquisition adds 36 operational dispensaries across Nevada, California, Florida, and Illinois, significantly expanding Vireo's multi-state cannabis retail presence.

  • Insider Lock-Up and Voting Agreements

    Key Planet 13 insiders, including founders Larry Scheffler, Robert Groesbeck, and Christopher Wren, signed voting agreements to support the deal and lock-up agreements restricting sales of Vireo shares received, with 5% released at closing and the remainder in tranches over 18 months.

  • Termination Fee and Deal Protections

    Planet 13 agreed to a $1.8 million termination fee payable to Vireo if the deal is terminated under certain circumstances, including accepting a superior proposal.


Analysis · VREOF · Life Sciences

Vireo Growth Inc. has entered into a definitive agreement to acquire Planet 13 Holdings Inc. in an all-stock transaction. Planet 13 shareholders will receive 0.015383618 Vireo subordinate voting shares for each Planet 13 share, implying a total issuance of approximately 5.6 million Vireo shares based on Planet 13's fully diluted share count. The deal significantly expands Vireo's retail presence, adding 36 dispensaries across key markets including Nevada, California, Florida, and Illinois. The merger is subject to shareholder and regulatory approvals, with a termination fee of $1.8 million payable by Planet 13 under certain conditions. Key Planet 13 insiders have entered into voting and lock-up agreements, with the lock-up releasing in tranches over 18 months post-closing. This acquisition continues Vireo's aggressive consolidation strategy in the U.S. cannabis market, following multiple recent acquisitions.

At the time of this filing, VREOF was trading at $9.37 on OTC in the Life Sciences sector, with a market capitalization of approximately $433.3M. The 52-week trading range was $8.91 to $24.00. This filing was assessed with positive market sentiment and an importance score of 9 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

VREOF - Latest Insights

VREOF
Jul 27, 2026, 8:51 AM EDT
Filing Type: 8-K
Importance Score:
9
VREOF
Jul 23, 2026, 4:05 PM EDT
Filing Type: 8-K
Importance Score:
8
VREOF
Jun 18, 2026, 5:17 PM EDT
Filing Type: 8-K/A
Importance Score:
9
VREOF
Jun 18, 2026, 4:05 PM EDT
Filing Type: 8-K
Importance Score:
8
VREOF
Jun 11, 2026, 4:06 PM EDT
Filing Type: 8-K
Importance Score:
9